145 related articles for article (PubMed ID: 26244491)
1. The Incidence of Cancer Among Acromegaly Patients: Results From the German Acromegaly Registry.
Petroff D; Tönjes A; Grussendorf M; Droste M; Dimopoulou C; Stalla G; Jaursch-Hancke C; Mai M; Schopohl J; Schöfl C
J Clin Endocrinol Metab; 2015 Oct; 100(10):3894-902. PubMed ID: 26244491
[TBL] [Abstract][Full Text] [Related]
2. Incidence of myocardial infarction and stroke in acromegaly patients: results from the German Acromegaly Registry.
Schöfl C; Petroff D; Tönjes A; Grussendorf M; Droste M; Stalla G; Jaursch-Hancke C; Störmann S; Schopohl J
Pituitary; 2017 Dec; 20(6):635-642. PubMed ID: 28808855
[TBL] [Abstract][Full Text] [Related]
3. Gender dependence of serum soluble Klotho in acromegaly.
Sze L; Neidert MC; Bernays RL; Zwimpfer C; Wiesli P; Haile SR; Brändle M; Schmid C
Clin Endocrinol (Oxf); 2014 Jun; 80(6):869-73. PubMed ID: 24330426
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of neoplasms in patients with acromegaly - the need for a national registry.
Matyjaszek-Matuszek B; Obel E; Lewicki M; Kowalczyk-Bołtuć J; Smoleń A
Ann Agric Environ Med; 2018 Sep; 25(3):559-561. PubMed ID: 30260174
[TBL] [Abstract][Full Text] [Related]
5. Conventional pituitary irradiation is effective in lowering serum growth hormone and insulin-like growth factor-I in patients with acromegaly.
Jenkins PJ; Bates P; Carson MN; Stewart PM; Wass JA
J Clin Endocrinol Metab; 2006 Apr; 91(4):1239-45. PubMed ID: 16403824
[TBL] [Abstract][Full Text] [Related]
6. Increased mortality in acromegaly is due to vascular and respiratory disease and is normalised by control of GH levels-A retrospective analysis from the UK Acromegaly Register 1970-2016.
Orme S; McNally R; James PW; Davis J; Ayuk J; Higham C; Wass J;
Clin Endocrinol (Oxf); 2024 Jun; 100(6):558-564. PubMed ID: 38652736
[TBL] [Abstract][Full Text] [Related]
7. The occurrence of thyroid focal lesions and a need for fine needle aspiration biopsy in patients with acromegaly due to an increased risk of thyroid cancer.
Ruchala M; Skiba A; Gurgul E; Uruski P; Wasko R; Sowinski J
Neuro Endocrinol Lett; 2009; 30(3):382-6. PubMed ID: 19855364
[TBL] [Abstract][Full Text] [Related]
8. The relationship between 24-hour growth hormone secretion and insulin-like growth factor I in patients with successfully treated acromegaly: impact of surgery or radiotherapy.
Peacey SR; Toogood AA; Veldhuis JD; Thorner MO; Shalet SM
J Clin Endocrinol Metab; 2001 Jan; 86(1):259-66. PubMed ID: 11232010
[TBL] [Abstract][Full Text] [Related]
9. The effects of long-term growth hormone and insulin-like growth factor-1 exposure on the development of cardiovascular, cerebrovascular and metabolic co-morbidities in treated patients with acromegaly.
Jayasena CN; Comninos AN; Clarke H; Donaldson M; Meeran K; Dhillo WS
Clin Endocrinol (Oxf); 2011 Aug; 75(2):220-5. PubMed ID: 21521288
[TBL] [Abstract][Full Text] [Related]
10. The relationship between serum GH and serum IGF-I in acromegaly is gender-specific.
Parkinson C; Ryder WD; Trainer PJ;
J Clin Endocrinol Metab; 2001 Nov; 86(11):5240-4. PubMed ID: 11701684
[TBL] [Abstract][Full Text] [Related]
11. Age and sex as predictors of biochemical activity in acromegaly: analysis of 1485 patients from the German Acromegaly Register.
Petersenn S; Buchfelder M; Gerbert B; Franz H; Quabbe HJ; Schulte HM; Grussendorf M; Reincke M;
Clin Endocrinol (Oxf); 2009 Sep; 71(3):400-5. PubMed ID: 19226273
[TBL] [Abstract][Full Text] [Related]
12. THE PREVALENCE OF CANCER AND ITS RELATION TO DISEASE ACTIVITY IN PATIENTS WITH ACROMEGALY: TWO CENTERS' EXPERIENCE.
Ucan B; Kizilgul M; Karci AC; Duger H; Erkam Sencar M; Imga NN; Demirci T; Berker D; Erman Cakal
Endocr Pract; 2021 Jan; 27(1):51-55. PubMed ID: 33475501
[TBL] [Abstract][Full Text] [Related]
13. The utility of oral glucose tolerance testing for diagnosis and assessment of treatment outcomes in 166 patients with acromegaly.
Carmichael JD; Bonert VS; Mirocha JM; Melmed S
J Clin Endocrinol Metab; 2009 Feb; 94(2):523-7. PubMed ID: 19033371
[TBL] [Abstract][Full Text] [Related]
14. The PPAR-gamma activator rosiglitazone fails to lower plasma growth hormone and insulin-like growth factor-1 levels in patients with acromegaly.
Bastemir M; Akin F; Yaylali GF
Neuroendocrinology; 2007; 86(2):119-23. PubMed ID: 17671378
[TBL] [Abstract][Full Text] [Related]
15. Serum IGF-I measured by four different immunoassays in patients with adult GH deficiency or acromegaly and in a control population.
Granada ML; Ulied A; Casanueva FF; Pico A; Lucas T; Torres E; Sanmartí A
Clin Endocrinol (Oxf); 2008 Jun; 68(6):942-50. PubMed ID: 17980002
[TBL] [Abstract][Full Text] [Related]
16. Incidence and risk factors of cancers in acromegaly: a Chinese single-center retrospective study.
Xiao T; Jiao R; Yang S; Wang Y; Bai X; Zhou J; Li R; Wang L; Yang H; Yao Y; Deng K; Gong F; Pan H; Duan L; Zhu H
Endocrine; 2023 Nov; 82(2):368-378. PubMed ID: 37442901
[TBL] [Abstract][Full Text] [Related]
17. GH and IGF-I excess control contributes to blood pressure control: results of an observational, retrospective, multicentre study in 105 hypertensive acromegalic patients on hypertensive treatment.
Colao A; Terzolo M; Bondanelli M; Galderisi M; Vitale G; Reimondo G; Ambrosio MR; Pivonello R; Lombardi G; Angeli A; degli Uberti EC
Clin Endocrinol (Oxf); 2008 Oct; 69(4):613-20. PubMed ID: 18410555
[TBL] [Abstract][Full Text] [Related]
18. Octreotide as primary therapy for acromegaly.
Newman CB; Melmed S; George A; Torigian D; Duhaney M; Snyder P; Young W; Klibanski A; Molitch ME; Gagel R; Sheeler L; Cook D; Malarkey W; Jackson I; Vance ML; Barkan A; Frohman L; Kleinberg DL
J Clin Endocrinol Metab; 1998 Sep; 83(9):3034-40. PubMed ID: 9745397
[TBL] [Abstract][Full Text] [Related]
19. Assessment of disease activity in treated acromegalic patients using a sensitive GH assay: should we achieve strict normal GH levels for a biochemical cure?
Costa AC; Rossi A; Martinelli CE; Machado HR; Moreira AC
J Clin Endocrinol Metab; 2002 Jul; 87(7):3142-7. PubMed ID: 12107214
[TBL] [Abstract][Full Text] [Related]
20. Homocysteine levels in acromegaly patients.
Hekimsoy Z; Ozmen B; Ulusoy S
Neuro Endocrinol Lett; 2005 Dec; 26(6):811-4. PubMed ID: 16380700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
